Detail Information of Xenobiotics
General Information of Xenobiotics (ID: XEO04522) | ||||||
---|---|---|---|---|---|---|
Xenobiotics Name |
Pentagalloylglucose
|
|||||
Xenobiotics Type |
Pharmaceutical Agent(s)
|
|||||
Classification |
Investigative Agent
|
|||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=65238"></iframe>
|
|||||
3D MOL | 2D MOL | |||||
PubChem CID | ||||||
DME(s) Modulated by This Xenobiotics | ||||||
DME(s) Inhibited by This Xenobiotics | ||||||
D-Lactate dehydrogenase (ldhA) | DME Info | Pseudomonas aeruginosa | [1] | |||
Arylamine N-acetyltransferase (NAT) | DME Info | Pseudomonas aeruginosa | [1] | |||
NADPH-dependent oxidoreductase (nfrA) | DME Info | Staphylococcus aureus | [1] | |||
Hydroxybenzoate 3-monooxygenase (pobA) | DME Info | Pseudomonas aeruginosa | [1] | |||
References | ||||||
1 | Inhibitory effects of 2,2'-dipyridyl and 1,2,3,4,6-penta-O-galloyl-b-D-glucopyranose on biofilm formation in contact lens cases. Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7053-7. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.